Nm23-H1 modulates the activity of the guanine exchange factor Dbl-1

International Journal of Cancer

Volumn 123, Issue 3, 2008, Pages 500-510

  Murakami, Masanao ^a   Meneses, Patricio I ^a,b   Knight, Jason S ^a   Lan, Ke ^a   Kaul, Rajeev ^a   Verma, Subhash C ^a   Robertson, Erie S ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Dbl 1; GEF; NDPK; Nm23; Oncoprotein

Indexed keywords

GUANOSINE TRIPHOSPHATE; NUCLEOSIDE DIPHOSPHATE KINASE A; ONCOPROTEIN; PROTEIN CDC42; PROTEIN DBL 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; BURKITT LYMPHOMA; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CYTOSKELETON; HUMAN; HUMAN CELL; LYMPHOMA CELL; MELANOMA; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM;

BLOTTING, WESTERN; CDC42 GTP-BINDING PROTEIN; CELL MOVEMENT; CLONE CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GTP-BINDING PROTEINS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOPRECIPITATION; MICROSCOPY, FLUORESCENCE; NEOPLASM METASTASIS; NM23 NUCLEOSIDE DIPHOSPHATE KINASES; ONCOGENE PROTEINS; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 45349104921     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23568     Document Type: Article

References (73)

1. Titus B, Schwartz MA, Theodorescu D. Rho proteins in cell migration and metastasis. Crit Rev Eukaryot Gene Expr 2005;15:103-14.
2. Palmieri D, Horak CE, Lee JH, Halverson DO, Steeg PS. Translational approaches using metastasis suppressor genes. J Bioenerg Biomembr 2006;38:151-61.
3. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, Sobel ME. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 1988;80:200-4.
4. Wallet V, Mutzel R, Troll H, Barzu O, Wurster B, Veron M, Lacombe ML. Dictyostelium nucleoside diphosphate kinase highly homologous to Nm23 and Awd proteins involved in mammalian tumor metastasis and Drosophila development. J Natl Cancer Inst 1990;82:1199-202.
5. Chandrachud LM, Grindlay GJ, McGarvie GM, O'Neil BW, Wagner ER, Jarrett WF, Campo MS. Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology 1995;211:204-8.
6. Tee YT, Chen GD, Lin LY, Ko JL, Wang PH. Nm23-H1: a metastasis-associated gene. Taiwan J Obstet Gynecol 2006;45:107-13.
7. Hartsough MT, Morrison DK, Salerno M, Palmieri D, Ouatas T, Mair M, Patrick J, Steeg PS. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway. J Biol Chem 2002;277:32389-99.
8. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O'Hara B, Eddy RL, Jr., Shows TB, Mathew S, Murty VV, Chaganti RS. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene 1993;8:497-502.
9. Gilles AM, Presecan E, Vonica A, Lascu I. Nucleoside diphosphate kinase from human erythrocytes. Structural characterization of the two polypeptide chains responsible for heterogeneity of the hexameric enzyme. J Biol Chem 1991;266:8784-9.
10. Bhujwalla ZM, Aboagye EO, Gillies RJ, Chacko VP, Mendola CE, Backer JM. Nm23-transfected MDA-MB-435 human breast carcinoma cells form tumors with altered phospholipid metabolism and pH: a 31P nuclear magnetic resonance study in vivo and in vitro. Magn Reson Med 1999;41:897-903.
11. de la Rosa A, Williams RL, Steeg PS. Nm23/nucleoside diphosphate kinase: toward a structural and biochemical understanding of its biological functions. Bioessays 1995;17:53-62.
12. Postel EH, Berberich SJ, Rooney JW, Kaetzel DM. Human NM23/ nucleoside diphosphate kinase regulates gene expression through DNA binding to nuclease-hypersensitive transcriptional elements. J Bioenerg Biomembr 2000;32:277-84.
13. Steeg PS, Ouatas T, Halverson D, Palmieri D, Salerno M. Metastasis suppressor genes: basic biology and potential clinical use. Clin Breast Cancer 2003;4:51-62.
14. MacDonald NJ, De la Rosa A, Benedict MA, Freije JM, Krutsch H, Steeg PS. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential. J Biol Chem 1993;268:25780-9.
15. Kantor JD, McCormick B, Steeg PS, Zetter BR. Inhibition of cell motility after nm23 transfection of human and murine tumor cells. Cancer Res 1993;53:1971-3.
16. Leone A, Flatow U, King CR, Sandeen MA, Margulies IM, Liotta LA, Steeg PS. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells. Cell 1991;65:25-35.
17. Kaul R, Murakami M, Choudhuri T, Robertson ES. Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model. J Virol 2007;81:10352-61.
18. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ, Steeg PS. Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 1993;8:855-65.
19. Hailat N, Keim DR, Melhem RF, Zhu XX, Eckerskorn C, Brodeur GM, Reynolds CP, Seeger RC, Lottspeich F, Strahler JR, Samir MH. High levels of p19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 1991;88:341-5.
20. Oda Y, Naka T, Takeshita M, Iwamoto Y, Tsuneyoshi M. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Hum Pathol 2000;31:709-16.
21. Nakamori S, Ishikawa O, Ohhigashi H, Kameyama M, Furukawa H, Sasaki Y, Inaji H, Higashiyama M, Imaoka S, Iwanaga T. Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin Exp Metastasis 1993;11:151-8.
22. Lieberman J, Fan Z. Nuclear war: the granzyme A-bomb. Curr Opin Immunol 2003;15:553-9.
23. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J. Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 2003;112:659-72.
24. Hall A. Rho GTPases and the actin cytoskeleton. Science 1998;279: 509-14.
25. Van Aelst L, D'souza-Schorey C. Rho GTPases and signaling networks. Genes Dev 1997;11:2295-322.
26. Boguski MS, McCormick F. Proteins regulating Ras and its relatives. Nature 1993;366:643-54.
27. Kraemer A, Brinkmann T, Plettner I, Goody R, Wittinghofer A. Fluorescently labelled guanine nucleotide binding proteins to analyse elementary steps of GAP-catalysed reactions. J Mol Biol 2002;324:763-74.
28. Garcia-Mata R, Burridge K. Catching a GEF by its tail. Trends Cell Biol 2007;17:36-43.
29. Ron D, Tronick SR, Aaronson SA, Eva A. Molecular cloning and characterization of the human dbl proto-oncogene: evidence that its overexpression is sufficient to transform NIH/3T3 cells. Embo J 1988;7:2465-73.
30. Eva A, Aaronson SA. Isolation of a new human oncogene from a diffuse B-cell lymphoma. Nature 1985;316:273-5.
31. Liu X, Mayeda A, Tao M, Zheng ZM. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3′ splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway. J Virol 2003;77:2105-15.
32. Eva A, Vecchio G, Diamond M, Tronick SR, Ron D, Cooper GM, Aaronson SA. Independently activated dbl oncogenes exhibit similar yet distinct structural alterations. Oncogene 1987;1:355-60.
33. Cerione RA, Zheng Y. The Dbl family of oncogenes. Curr Opin Cell Biol 1996;8:216-22.
34. Whitehead IP, Campbell S, Rossman KL, Der CJ. Dbl family proteins. Biochim Biophys Acta 1997;1332:F1-23.
35. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, et al. The sequence of the human genome. Science 2001;291: 1304-51.
36. Schmidt A, Hall A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev 2002;16:1587-609.
37. Subramanian C, Cotter MA, 2nd, Robertson ES. Epstein-Barr virus nuclear protein EBNA-3C interacts with the human metastatic suppressor Nm23-H1: a molecular link to cancer metastasis. Nat Med 2001;7:350-5.
38. Kaul R, Verma SC, Murakami M, Lan K, Choudhuri T, Robertson ES. Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1. J Virol 2006;80:1321-31.
39. Murakami M, Lan K, Subramanian C, Robertson ES. Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration. J Virol 2005;79:1559-68.
40. Ouatas T, Salerno M, Palmieri D, Steeg PS. Basic and translational advances in cancer metastasis: Nm23. J Bioenerg Biomembr 2003; 35:73-9.
41. Freije JM, Blay P, MacDonald NJ, Manrow RE, Steeg PS. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro. J Biol Chem 1997; 272:5525-32.
42. Wagner PD, Steeg PS, Vu ND. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity. Proc Natl Acad Sci U S A 1997;94:9000-5.
43. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. Embo J 1984;3:1151-7.
44. Graziani G, Ron D, Eva A, Srivastava SK. The human dbl-proto-oncogene product is a cytoplasmic phosphoprotein which is associated with the cytoskeletal matrix. Oncogene 1989;4:823-9.
45. Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003;3:55-63.
46. Zhu K, Debreceni B, Bi F, Zheng Y. Oligomerization of DH domain is essential for Dbl-induced transformation. Mol Cell Biol 2001;21: 425-37.
47. Bi F, Debreceni B, Zhu K, Salani B, Eva A, Zheng Y. Autoinhibition mechanism of proto-Dbl. Mol Cell Biol 2001;21:1463-74.
48. Kauppinen KP, Duan F, Weis JI, Manor D. Regulation of the Dbl proto-oncogene by heat shock cognate protein 70 (Hsc70). J Biol Chem 2005;280:21638-44.
49. Kamynina E, Kauppinen K, Duan F, Muakkassa N, Manor D. Regulation of proto-oncogenic dbl by chaperone-controlled, ubiquitin-mediated degradation. Mol Cell Biol 2007;27:1809-22.
50. Ron D, Graziani G, Aaronson SA, Eva A. The N-terminal region of proto-dbl down regulates its transforming activity. Oncogene 1989;4:1067-72.
51. van Leeuwen FN, van der Kammen RA, Habets GG, Collard JG. Oncogenic activity of Tiam1 and Rac1 in NIH3T3 cells. Oncogene 1995;11:2215-21.
52. Chan AM, Takai S, Yamada K, Miki T. Isolation of a novel oncogene, NET1, from neuroepithelioma cells by expression cDNA cloning. Oncogene 1996;12:1259-66.
53. Katzav S, Cleveland JL, Heslop HE, Pulido D. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential. Mol Cell Biol 1991;11:1912-20.
54. Kawasaki Y, Senda T, Ishidate T, Koyama R, Morishita T, Iwayama Y, Higuchi O, Akiyama T. Asef, a link between the tumor suppressor APC and G-protein signaling. Science 2000;289:1194-7.
55. Miki T, Smith CL, Long JE, Eva A, Fleming TP. Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature 1993; 362:462-5.
56. Vanni C, Mancini P, Gao Y, Ottaviano C, Guo F, Salani B, Torrisi MR, Zheng Y, Eva A. Regulation of proto-Dbl by intracellular membrane targeting and protein stability. J Biol Chem 2002;277:19745-53.
57. Bokoch GM. Regulation of cell function by Rho family GTPases. Immunol Res 2000;21:139-48.
58. Bar-Sagi D, Hall A. Ras and Rho GTPases: a family reunion. Cell 2000;103:227-38.
59. Hart MJ, Callow MG, Souza B, Polakis P. IQGAP1, a calmodulin-binding protein with a rasGAP-related domain, is a potential effector for cdc42Hs. Embo J 1996;15:2997-3005.
60. Kuroda S, Fukata M, Kobayashi K, Nakafuku M, Nomura N, Iwamatsu A, Kaibuchi K. Identification of IQGAP as a putative target for the small GTPases, Cdc42 and Rac1. J Biol Chem 1996;271:23363-7.
61. Fukata M, Kuroda S, Nakagawa M, Kawajiri A, Itoh N, Shoji I, Matsuura Y, Yonehara S, Fujisawa H, Kikuchi A, Kaibuchi K. Cdc42 and Rac1 regulate the interaction of IQGAP1 with beta-catenin. J Biol Chem 1999;274:26044-50.
62. Kuroda S, Fukata M, Nakagawa M, Fujii K, Nakamura T, Ookubo T, Izawa I, Nagase T, Nomura N, Tani H, Shoji I, Matsuura Y, et al. Role of IQGAP1, a target of the small GTPases Cdc42 and Rac1, in regulation of E-cadherin- mediated cell-cell adhesion. Science 1998;281:832-5.
63. Hordijk PL, ten Klooster JP, van der Kammen RA, Michiels F, Oomen LC, Collard JG. Inhibition of invasion of epithelial cells by Tiam1-Rac signaling. Science 1997;278:1464-6.
64. Habets GG, Scholtes EH, Zuydgeest D, van der Kammen RA, Stam JC, Berns A, Collard JG. Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for Rho-like proteins. Cell 1994;77:537-49.
65. Michiels F, Habets GG, Stam JC, van der Kammen RA, Collard JG. A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 1995;375:338-40.
66. Qian X, Vass WC, Papageorge AG, Anborgh PH, Lowy DR. N terminus of Sos1 Ras exchange factor: critical roles for the Dbl and pleckstrin homology domains. Mol Cell Biol 1998;18:771-8.
67. Owen JD, Ruest PJ, Fry DW, Hanks SK. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol Cell Biol 1999;19:4806-18.
68. Rozengurt E, Rodriguez-Fernandez JL. Tyrosine phosphorylation in the action of neuropeptides and growth factors. Essays Biochem 1997;32:73-86.
69. Powelka AM, Sun J, Li J, Gao M, Shaw LM, Sonnenberg A, Hsu VW. Stimulation-dependent recycling of integrin beta1 regulated by ARF6 and Rab11. Traffic 2004;5:20-36.
70. Choudhuri T, Verma SC, Lan K, Robertson ES. Expression of alpha V integrin is modulated by Epstein-Barr virus nuclear antigen 3C and the metastasis suppressor Nm23-H1 through interaction with the GATA-1 and Sp1 transcription factors. Virology 2006;351:58-72.
71. D'Angelo A, Garzia L, Andre A, Carotenuto P, Aglio V, Guardiola O, Arrigoni G, Cossu A, Palmieri G, Aravind L, Zollo M. Prune cAMP phosphodiesterase binds nm23-H1 and promotes cancer metastasis. Cancer Cell 2004;5:137-49.
72. Tatsumoto T, Xie X, Blumenthal R, Okamoto I, Miki T. Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/ M phases, and involved in cytokinesis. J Cell Biol 1999;147:921-8.
73. Valentijn LJ, Koppen A, van Asperen R, Root HA, Haneveld F, Versteeg R. Inhibition of a new differentiation pathway in neuroblastoma by copy number defects of N-myc, Cdc42, and nm23 genes. Cancer Res 2005;65:3136-45.